By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Lejrvej 37-41

Værløse    DK-3500  Denmark
Phone: 45-44-47-80-80 Fax: 45-44-47-24-25



Company News
Egalet Appoints Nicholas Nicolaides, Ph.D. And John Osborn To Board of Directors 4/13/2015 6:29:46 AM
Egalet Announces Closing Of $60 Million Offering of Convertible Senior Notes Due 2020 4/8/2015 6:18:45 AM
Egalet Announces Proposed $60 Million Offering Of Convertible Senior Notes Due 2020 4/1/2015 6:59:47 AM
Egalet Provides Commercial Update On SPRIX And OXAYDO 3/25/2015 6:24:00 AM
Egalet Earns $10 Million Milestone Payment Triggered By Advancement Of Shionogi, Inc.'s Abuse-Deterrent, Extended-Release Hydrocodone, S-718632, Using Egalet's GuardianTechnology 3/17/2015 7:06:26 AM
Egalet Reports Full Year 2014 Financial Results 3/16/2015 9:46:50 AM
Egalet Accelerates Development Of Abuse-Deterrent Morphine Egalet-001 And Plans To File New Drug Application In The Fourth Quarter 3/11/2015 6:59:44 AM
Egalet To Release 2014 Fourth Quarter And Year-End Financial Results On March 16, 2015 And To Host Conference Call And Webcast To Discuss Commercial Launch On March 25, 2015 3/9/2015 8:13:42 AM
Egalet To Present At Upcoming Conferences In February 2/2/2015 11:59:47 AM
Egalet Announces Positive Top-Line Results From Oral Human Abuse Liability Study Of Abuse-Deterrent Morphine, Egalet-001 1/22/2015 7:55:22 AM